BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Arena Pharmaceuticals, Inc. 

6166 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 858-453-7200 Fax: 858-453-7210


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Lexicon Genetics Incorporated 

Merck & Co., Inc.  Cardiovascular





 Company News
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA) 8/25/2014 3:19:23 AM
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014 7:28:10 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Post-Hoc Analyses Of Lorcaserin Phase 3 Clinical Trial Results In Obesity 7/30/2014 8:22:26 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce BELVIQ® (lorcaserin HCl) CIV Nominated A Second Time For The Prix Galien Award In The Best Pharmaceutical Agent Category 7/29/2014 8:04:43 AM
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014 9:00:22 AM
Arena Pharmaceuticals, Inc. (ARNA) Enters Into Marketing And Supply Agreement For BELVIQ® (Lorcaserin Hcl) In Israel 7/21/2014 11:56:56 AM
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014 9:48:14 AM
Arena Pharmaceuticals, Inc. (ARNA) Reports That Eisai Inc. (ESALF.PK) Completes Planned Increase In Sales Force For BELVIQ® (Lorcaserin Hcl) CIV 7/10/2014 10:09:06 AM
Arena Pharmaceuticals, Inc. (ARNA) To Present At The 2014 Wells Fargo Securities Healthcare Conference 6/13/2014 7:05:57 AM
Arena Pharmaceuticals, Inc. (ARNA) Initiates Phase 1b Clinical Trial Of APD334 For Autoimmune Diseases 6/3/2014 9:28:57 AM
12345678910...